Kristin Idaszak
Affiliated Writer
Chicago, IL

Kristin Idaszak is a Chicago-based playwright and performance maker. Her play Second Skin received the Kennedy Center’s Paula Vogel Playwriting Award and the Jean Kennedy Smith Playwriting Award. Her play Fugue for Particle Accelerator received its world premiere at 20% Theatre Company Chicago. Her work has also been developed through residencies at the city of Chicago’s Department of Cultural Affairs, Stage Left Theatre, and the Qualcomm Institute at Calit2 in San Diego. Kristin has co-created collaborative original work that has been seen at the WoW Festival at La Jolla Playhouse and the Blurred Borders Festival, an international showcase of contemporary dance theatre. She has been nominated for a Joseph Jefferson Award for Best New Work and an received an honorable mention on the Kilroys’ List. She was the 2015 Kennedy Center Fellow at the Sundance Theatre Lab. She has received two Playwrights’ Center Jerome Fellowships and is the Shank Playwright in Residence at the Goodman Theatre. Previously, Kristin served as Associate Artistic Director/Literary Manager of Caffeine Theatre and Associate Artistic Director of Collaboraction. MFA: University of California, San Diego. BFA: The Theatre School at DePaul University.



Kristin Idaszak's The Surest Poison (workshopped at PWC) is a finalist of the 2019 Blue Ink Playwriting Award, presented by the American Blues Theater:

The world premiere of Kristin's play SECOND SKIN is currently running as the final production of WildClaw Theatre's 10th season. Performances are at the Den Theatre in Chicago through October 13:

Kristin has been named a Resident Playwright at Chicago Dramatists and will receive six years of development support.

Kristin Idaszak is one of five Chicago-based playwrights newly named to the Playwrights Unit, a year-long residency in partnership with Chicago Dramatists. Click here for more information.

Kristin Idaszak's play The Surest Poison awarded 2016/2017 EST/Sloan Commission! See the link for more info: